Topic

Muscular dystrophy Steady

440 applications whose title mentions it. Its share of new filings over the last two years is 8% above the four years before.

Allowance rate

54%

−22 pts vs the USPTO 325 decided

Months to first action

18.1 mo

−0.5 vs the USPTO

Applications

440.0

in the record

Allowed

174.0

151 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K267 apps

C12N93 apps

C07K34 apps

A61P16 apps

C12Q11 apps

G01N6 apps

Art units

163596 apps

OPAP38 apps

163631 apps

167430 apps

163329 apps

163720 apps

Examiners

Who examines it, and how it fares with each

Dana H Shin47 apps

31%

Docket Central39 apps

n/a

Kimberly Chong17 apps

79%

Ekaterina Poliakova-Georgan16 apps

38%

Brian A Whiteman14 apps

77%

Ruixiang Li11 apps

64%

Craig D Ricci10 apps

90%

Richard A Schnizer9 apps

67%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

Sarepta Therapeutics, Inc.74 apps

32%

RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL37 apps

68%

Dyne Therapeutics, Inc.18 apps

92%

Academisch Ziekenhuis Leiden14 apps

33%

Avidity Biosciences, Inc.13 apps

100%

The Charlotte Mecklenburg Hospital Authority d/b/a Atrium Health12 apps

91%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.78 apps

30%

FOLEY & LARDNER LLP39 apps

70%

Dyne Therapeutics, Inc.18 apps

92%

Knobbe, Martens, Olson & Bear, LLP15 apps

64%

SCHWABE WILLIAMSON& WYATT15 apps

93%

Novartis/Finnegan13 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19628528	ENDOXIFEN FOR TREATING DUCHENNE MUSCULAR DYSTROPHY	2026-09-25	Pending	0	0	n/a
19621367	METHOD FOR TREATING MUSCULAR DYSTROPHY BY TARGETING LAMA1 GENE	2026-09-04	Pending	0	0	n/a
19722434	ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND MICRORNA-29 AND THE TRE…	2026-06-26	Pending	0	0	n/a
15443713	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15658430	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15554990	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15865413	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15472436	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15724522	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15711765	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in